Characterization with Atomic Force Microscopy, Topographic, and 3D Raman

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-15-2013
Volume 2013 eBook
Issue 1

The authors describe how a combination of imaging techniques can be used to provide topographic and chemical information to characterize a sample.

 

Highly specified drug-delivery systems require specific quality evaluation during the development stage. The authors describe how a combination of imaging techniques can be used to provide topographic and chemical information to characterize a sample three-dimensionally, underneath, and at the surface in a nondestructive manner.

View 

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

.

 

 

 

 

Articles in this issue
pt-ebook_chrom.jpg
Impurity Profiling Using Convergence Chromatography and Mass Spectrometry
pt_ebooks_nmr.jpg
Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis
pt_ebooks_lcms.jpg
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations
pt_ebooks_protein.jpg
Identification and Quantification of Trace-Level Protein Impurities
pt_ebooks_hplc.jpg
Ultra-High-Speed Analysis of Ibuprofen Using HPLC
pt_ebooks_microscopy.jpg
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Analytical Services with GMP Cell-Based Potency Testing in US and UK

Feliza Mirasol
November 22nd 2024
Article

The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol
November 21st 2024
Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol
November 20th 2024
Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.